Health Trials

Cytomegalovirus Prophylaxis

2

Review clinical trials related to Cytomegalovirus Prophylaxis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to: * Learn what happens to letermovir in the body over time * Learn about the safety of letermovir and if participants tolerate it

Participants needed: 40
Trial details
Phase: Phase 1Age: Up to 17Biological sex: AllType: InterventionalSponsor: Merck Sharp & Dohme LLCUpdated: Jul 13, 2026Locations: 18
Eligibility criteria

Is a recipient of a primary or secondary allograft kidney [+6]

Has CMV disease or suspected CMV disease between screening and enrollment [+7]

Read more
Status: Recruiting

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the study are to: * Learn what happens to letermovir in the body over time * Learn about the safety of letermovir and if participants tolerate it

Participants needed: 40
Trial details
Phase: Phase 1Age: Up to 17Biological sex: AllType: InterventionalSponsor: Merck Sharp & Dohme LLCUpdated: Jun 12, 2026Locations: 17
Eligibility criteria

Is a recipient of a primary or secondary allograft kidney [+6]

Has CMV disease or suspected CMV disease between screening and enrollment [+7]

Read more